We reduced our fair value estimate to $15.50 per share from $27.20 to account for greater headwinds as a newly stand-alone company since its spinoff from Labcorp in 2023, which will weigh on revenue ...

5Department of Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 6Department of Pharmaco-Therapy, -Epidemiology and- Economy, ...

and resulting in caspase activation through a decrease in the Bcl-2/Bax protein ratio (Zhang et al., 2011). Other molecules with therapeutic potential that are yet to be examined in melanoma are ...